Grifols Stock Price, News & Analysis
Company Description
Grifols (OTC Link: GIKLY) is a publicly traded drug manufacturers - general company in the Healthcare sector. The company has a market capitalization of $8.7B.
GIKLY stock has gained 8.6% over the past year. Shares last traded at $5.18.
This page provides a comprehensive overview of GIKLY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Grifols (GIKLY) stock last traded at $5.18. Over the past 12 months, the stock has gained 8.6%. At a market capitalization of $8.7B, GIKLY is classified as a mid-cap stock with approximately 1.1B shares outstanding.
Latest News
Grifols has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 0 with negative movement. Key topics include management, partnership, acquisition. View all GIKLY news →
SEC Filings
Grifols has filed 10 recent SEC filings, including 6 Form 6-K, 2 Form 20-F, 2 Form SCHEDULE 13G/A. The most recent filing was submitted on April 17, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all GIKLY SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Grifols (GIKLY) currently stands at 69 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 82.8%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Grifols (GIKLY) currently stands at 1.0 days, down 36.3% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 20.6% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
GIKLY Company Profile & Sector Positioning
Grifols (GIKLY) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing GIKLY often look at related companies in the same sector, including Kyowa Hakko (KYKOY), Ono Pharmace Drc (OPHLY), Pt Kalbe Farma Tbk (PTKFY), Cspc Pharmaceuti (CSPCY), and Astellas Pharma (ALPMY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GIKLY's relative position within its industry.